Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:403 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 403(2024), 10432 vom: 23. März, Seite 1133-1136 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shawe-Taylor, Marianne [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(24)00316-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369744403 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369744403 | ||
| 003 | DE-627 | ||
| 005 | 20240325235221.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(24)00316-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM369744403 | ||
| 035 | |a (NLM)38484752 | ||
| 035 | |a (PII)S0140-6736(24)00316-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shawe-Taylor, Marianne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Greenwood, David |e verfasserin |4 aut | |
| 700 | 1 | |a Hobbs, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Dowgier, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Penn, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Sanderson, Theo |e verfasserin |4 aut | |
| 700 | 1 | |a Stevenson-Leggett, Phoebe |e verfasserin |4 aut | |
| 700 | 1 | |a Bazire, James |e verfasserin |4 aut | |
| 700 | 1 | |a Harvey, Ruth |e verfasserin |4 aut | |
| 700 | 0 | |a Crick COVID Serology Pipeline Investigators, Legacy Investigators |e verfasserin |4 aut | |
| 700 | 1 | |a Libri, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Kassiotis, George |e verfasserin |4 aut | |
| 700 | 1 | |a Gamblin, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Lewis, Nicola S |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Swanton, Charles |e verfasserin |4 aut | |
| 700 | 1 | |a Gandhi, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Carr, Edward J |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Mary Y |e verfasserin |4 aut | |
| 700 | 1 | |a Bauer, David L V |e verfasserin |4 aut | |
| 700 | 1 | |a Wall, Emma C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 403(2024), 10432 vom: 23. März, Seite 1133-1136 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:403 |g year:2024 |g number:10432 |g day:23 |g month:03 |g pages:1133-1136 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(24)00316-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 403 |j 2024 |e 10432 |b 23 |c 03 |h 1133-1136 | ||